PURE to start poultry processing trial for antimicrobial

By Joseph James Whitworth

- Last updated on GMT

Poultry plant trial for SDC-based PURE Control antimicrobial

Related tags Microbiology

PURE Bioscience has received a permission letter from the USDA’s Food Safety and Inspection Service (FSIS) granting approval for an in-plant poultry processing trial of SDC-based PURE Control antimicrobial.

The silver dihydrogen citrate (SDC) antimicrobial reduces pathogens including Salmonella, said the firm.

PURE Control will be spray applied to whole chicken carcasses during online and offline reprocessing and will replace the processing aid currently being used by the plant.

The two phase trial will start within the next two weeks and will last four-six weeks.

Samples will be randomly pulled and tested for microbial efficacy and residues. The processed poultry will be sold to consumers. In Phase II, additional post chill poultry parts will be evaluated using a dip after completion of Phase I.

Assuming it is a success, PURE anticipates the USDA-FSIS will issue a “Letter of No Objection” and the firm will begin commercial sale upon its receipt, with the trial plant processor anticipated to become the first customer.

Hank Lambert, CEO, said: “We have been engaged in discussions with major poultry processors in anticipation of approval - and interest is strong in our solution to help processors protect customers and their brand.

“Within three to five years, we expect to achieve poultry processing aid sales representing a meaningful share of the $350m US market. Simultaneously, we have already begun commercializing PURE Control in the $300m US fresh produce processing aid market where we also anticipate generating significant market share.”

Related topics Food Safety & Quality

Related news

Show more